- "11th Symposium on Pharmaceutical Profiling in Drug Discovery and Development" uppskjutet till januari 2022 2021-01-21
- 16.68 miljoner till forskning vid farmaceutiska fakulteten 2020-11-16
- Professor Per Artursson: Giant of Pharmaceutical Sciences 2020-11-11
- Doktorandtjänst inom läkemedelsexponering i kolon 2020-11-11
- Maria Karlgren tilldelas IQ-konsortiets och AAALAC:s internationella 3R-utmärkelse för år 2020 2020-10-30
Hammar, Rebekkah; Sellin, Mikael E.; Artursson, Per
Epithelial and microbial determinants of colonic drug distribution
Lundquist, Patrik; Khodus, Georgiy; Niu, Zhigao; Thwala, Lungile Nomcebo; McCartney, Fiona; Simoff, Ivailo; Andersson, Ellen; Beloqui, Ana; Mabondzo, Aloise; Robla, Sandra; Webb, Dominic-Luc; Hellström, Per M.; Keita, Åsa V; Sima, Eduardo; Csaba, Noemi; Sundbom, Magnus; Preat, Veronique; Brayden, David J; Alonso, Maria Jose; Artursson, Per
Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat
Kvitne, Kine Eide; Hole, Kristine; Krogstad, Veronica; Wollmann, Birgit Malene; Wegler, Christine; Johnson, Line K.; Hertel, Jens K.; Artursson, Per; Karlsson, Cecilia; Andersson, Shalini; Andersson, Tommy B.; Sandbu, Rune; Hjelmesaeth, Joran; Skovlund, Eva; Christensen, Hege; Jansson-Lofmark, Rasmus; Asberg, Anders; Molden, Espen; Robertsen, Ida
Correlations between 4 beta-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range
We aim to understand drug delivery and disposition at the molecular and cellular level in order to deliver drugs more effectively. We also focus on the distribution and function of important drug-transporting proteins in the human body to understand drug disposition and drug-drug interactions better.
We take a multidisciplinary approach to define rate-limiting barriers to the absorption and organ and cellular distribution of different types of drugs and to characterize drug transport routes across organ barriers in important pharmacokinetic organs such as the intestine, liver and kidney. For this purpose, we combine computational chemistry and bioinformatics with cell- and molecular biology, omics, biopharmaceutics, pharmaceutics and physical chemistry to find new ways to predict drug absorption and delivery.
Our research has provided insights into new mechanisms for drug absorption, exposure, disposition and delivery, and suggested new therapeutic strategies for efficient drug delivery. It has also evolved to the National and European resource UDOPP (Uppsala University Drug Optimization and Pharmaceutical Profiling Platform). UDOPP supports academic and industrial discovery projects with absorption, distribution, metabolism and elimination (ADME) as well as profiling of compound libraries, hits and leads. UDOPP also performs pharmacokinetic and dynamic modelling prior to preclinical and clinical studies.